Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umut Demirci

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Future Oncology (London, England)|November 2, 2021
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium databaseEmre Yekedüz, İsmail Ertürk, Deniz Tural, et al.
Scientific Reports|July 7, 2026
Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician-patient surveyIrfan Cicin, Taha Bahsi, Fatih Kose, et al.
Clinical Genitourinary Cancer|August 15, 2022
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) DatabaseEmre Yekedüz, Serdar Karakaya, İsmail Ertürk, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Clinicopathological features in bilateral breast cancerMeltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyOzge Gumusay, Ugur Coskun, Tülay Akman, et al.
International Surgery|January 22, 2014
Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)Ali Inal, Tulay Akman, Sebnem Yaman, et al.
Annali Italiani Di Chirurgia|May 24, 2013
Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical OncologyAli Inal, Tulay Akman, Sebnem Yaman, et al.
Thoracic Cancer|January 15, 2016
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancerNedim Turan, Mustafa Benekli, Faysal Dane, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2023
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?Gürkan Güner, Burak Yasin Aktaş, Fatma Buğdaycı Başal, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Future Oncology (London, England)|November 2, 2021
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium databaseEmre Yekedüz, İsmail Ertürk, Deniz Tural, et al.
Scientific Reports|July 7, 2026
Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician-patient surveyIrfan Cicin, Taha Bahsi, Fatih Kose, et al.
Clinical Genitourinary Cancer|August 15, 2022
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) DatabaseEmre Yekedüz, Serdar Karakaya, İsmail Ertürk, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Clinicopathological features in bilateral breast cancerMeltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyOzge Gumusay, Ugur Coskun, Tülay Akman, et al.
International Surgery|January 22, 2014
Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)Ali Inal, Tulay Akman, Sebnem Yaman, et al.
Annali Italiani Di Chirurgia|May 24, 2013
Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical OncologyAli Inal, Tulay Akman, Sebnem Yaman, et al.
Thoracic Cancer|January 15, 2016
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancerNedim Turan, Mustafa Benekli, Faysal Dane, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2023
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?Gürkan Güner, Burak Yasin Aktaş, Fatma Buğdaycı Başal, et al.
Pageof 12